You have probably been hearing much about CBD oil recently – and with good reason. This all-natural, hemp-derived oil has demonstrated promise for everything from chronic pain relief to help with sleep and anxiety. But all CBD oil is not created equal. Some brands contain synthetic ingredients, while others contain insufficient amounts of active ingredients. CBD oil from MARK3 is full spectrum oil: the most desirable type of cannabidiol oil available. So what does “full spectrum oil” mean? In short, full spectrum CBD oil contains all of the active cannabinoids found in the hemp plant, providing patients with the maximum therapeutic benefits. Here are the details:
CBD oil contains cannabidiol, the most plentiful cannabinoid in the hemp plant, comprising around 90% of all cannabinoids. CBD has been thoroughly researched, and studies continue. So far, researchers have attributed anti-inflammatory, analgesic, anti-anxiety, anti-nausea, and positive sleep effects to consumption of CBD.
Cannabidiolic acid (CBDa) is a cousin of CBD. Scientists have not yet studied CBDa to the same extent as CBD, but early research looks extremely promising. CBDa has shown positive effects on nausea and anxiety in animal studies. CBDa may even restrict the spread of breast cancer cells.
Cannabinol (CBN) has not undergone extensive research, but preliminary studies are again encouraging. CBN is a natural degradation of THC, the compound that causes the psychoactive high associated with marijuana. Unlike THC though, CBN is barely psychoactive. in animal studies , cannabinol has been shown to prolong sleep, stimulate appetite, reduce anxiety, and promote strong bones. In addition, CBN has antibacterial properties, killing pathogenic bacteria when applied topically to the skin.
Cannabigerol (CBG) is another cannabinoid present in MARK3 CBD Oil. Researchers have proven that CBG stimulates appetite in animals, which is good news for people who suffer the effects of chronic diseases. Furthermore, CBG has demonstrated the potential to guard against the effects of Huntington’s disease, a devastating neurodegenerative disorder.
Cannabichromene (CBC) has not yet been well-studied but seems to help alleviate microorganism-induced colitis in mice. This is not surprising when one considers that CBC has also shown generalized anti-inflammatory effects. Current research is now focusing on potential anti-anxiety and anti-depressive properties of CBC.
Cannabichromenic acid (CBCa) is a precursor of CBC. Over time, CBCa naturally degrades into CBC. There is currently a paucity of research on this promising cannabinoid. What we do know is that CBCa is not psychoactive and potentially produces anti-inflammatory effects in humans.